Franklin Biotechnology Discovery Fund Advisor (FTDZX)
193.80
+0.68
(+0.35%)
USD |
Dec 05 2025
FTDZX Asset Allocations & Exposures
Asset Allocation
As of October 31, 2025.
| Type | % Net |
|---|---|
| Cash | -0.25% |
| Stock | 95.43% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.72% |
| Other | 4.09% |
Market Capitalization
As of October 31, 2025
| Large | 34.10% |
| Mid | 13.99% |
| Small | 51.91% |
Region Exposure
| Americas | 74.05% |
|---|---|
|
North America
|
74.05% |
| Canada | 0.75% |
| United States | 73.30% |
|
Latin America
|
0.00% |
As of October 31, 2025. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 20.97% |
|---|---|
| United Kingdom | 3.32% |
|
Europe Developed
|
17.66% |
| Denmark | 3.32% |
| France | 2.12% |
| Germany | 0.27% |
| Ireland | 4.02% |
| Netherlands | 7.47% |
| Switzerland | 0.46% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.00% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.00% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 4.98% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
94.94% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
94.94% |
| Utilities |
|
0.00% |
| Not Classified |
|
5.06% |
| Non Classified Equity |
|
0.88% |
| Not Classified - Non Equity |
|
4.18% |
As of October 31, 2025
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |